Group 1 - The company plans to reduce the registered capital of its wholly-owned subsidiary, Huaxiang Asset Management Co., Ltd., from 400 million RMB to 105 million RMB, optimizing resource allocation and aligning with its business development strategy [2][4][5] - The board of directors approved the capital reduction on April 27, 2025, and it does not require shareholder meeting approval as it does not constitute a related party transaction or a major asset restructuring [2][5][6] - As of December 31, 2024, Huaxiang Asset Management had total assets of approximately 105.68 million RMB and a net profit of approximately 6.82 million RMB, despite having zero operating revenue [3] Group 2 - The company intends to dissolve its wholly-owned subsidiary, Anhui Hongguang Window Industry Co., Ltd., which has been inactive since April 2023, to focus on its core business and optimize resource allocation [7][9][10] - The dissolution will not significantly impact the company's overall business development or profitability, as the subsidiary's operations accounted for a low proportion of the company's total business [10] - The board of directors authorized the management team to handle the necessary procedures for the dissolution, which does not require shareholder meeting approval [7][10] Group 3 - The company plans to use up to 50 million RMB of temporarily idle funds for wealth management or entrusted financial products to enhance fund utilization efficiency and increase returns [12][13][23] - The investment will focus on high-security, liquid financial products, with the board having approved this plan on April 27, 2025, without needing shareholder approval [20][21][23] - The investment strategy aims to maximize financial management benefits while ensuring the safety of the company's funds [14][23] Group 4 - The company will hold its 2024 annual shareholder meeting on May 19, 2025, with both onsite and online voting options available [26][27] - The meeting will address various proposals, including the profit distribution plan for 2024, and will not involve any special resolutions or related party transactions [32][33][10] - Shareholders must register to attend the meeting, with specific procedures outlined for both individual and corporate shareholders [39][43]

Group 1 - The company board has proposed to hold the 2024 Annual General Meeting on May 15, 2025, combining on-site and online voting methods [4][5][7] - The meeting will take place at the company's conference room located at No. 21 Changsheng Street, Luquan Economic Development Zone, Shijiazhuang, Hebei Province [6] - The voting will be conducted through the Shenzhen Stock Exchange trading system and internet voting system, with specific time slots for each [5][7][21][22] Group 2 - The company has confirmed that the meeting's legality and compliance have been reviewed and approved by the board [4] - The record date for shareholders to attend the meeting is set for May 9, 2025 [9] - Shareholders can appoint proxies to attend the meeting and vote on their behalf [9][12] Group 3 - The board has approved several proposals to be submitted for shareholder voting, including the 2024 annual financial report and profit distribution plan [10][30][33] - The profit distribution plan proposes a cash dividend of 4.20 yuan per 10 shares, totaling a distribution amount that does not exceed the retained earnings [33] - The company reported total assets of 7.591 billion yuan and net assets of 6.034 billion yuan as of December 31, 2024, with a revenue of 2.648 billion yuan and a net profit of 613 million yuan for the year [29] Group 4 - The company plans to use part of its idle raised funds for cash management, with an amount not exceeding 1.83 billion yuan [48] - The company will also seek a comprehensive credit facility from banks not exceeding 700 million yuan to meet its operational funding needs [56] - The company has established a management method for raised funds to ensure compliance with relevant regulations and protect investor interests [68][69]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：301207 证券简称：华兰疫苗公告编号：2025-022 华兰生物疫苗股份有限公司 关于召开2024年度股东大会的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 华兰生物疫苗股份有限公司（以下简称"公司"）已于2025年3月29日在《证券时报》、《中国证券 报》、《上海证券报》及巨潮资讯网（www.cninfo.com.cn）披露了《关于召开2024年度股东大会的通 知》（公告编号：2025-020）。本次股东大会采取现场投票和网络投票相结合的表决方式召开，根据有 关规定，现将股东大会的相关事项再次提示如下： 一、召开会议的基本情况 1、股东大会届次：2024年度股东大会； 2、股东大会召集人：公司董事会； 3、会议召开的合法、合规性：本次股东大会会议的召开符合有关法律、行政法规、部门规章、规范性 文件和公司章程的规定。 4、会议召开方式：现场投票+网络投票 （1）现场投票：股东本人出席现场会议或者通过授权委托书（附件二）委托他人出席现场会议； （2）网络投票：本次股东大会通过深圳证券交 ...

证券代码：300119 证券简称：瑞普生物 公告编号：2025-028 瑞普生物股份有限公司 关于召开 2024 年年度股东大会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 一、本次股东大会召开的基本情况 会决定召开2024年年度股东大会。 式。 （1）现场投票：包括本人出席及通过填写授权委托书授权他人出席。 （2）网络投票：公司将通过深圳证券交易所交易系统和互联网投票系统向 股东提供网络形式的投票平台，公司股东应在本通知列明的有关时限内通过深 圳证券交易所的交易系统或互联网投票系统进行网络投票。 公司股东只能选择现场投票、网络投票中的一种表决方式，如同一股东账 户通过以上两种方式重复表决的，以第一次投票结果为准。 （1）在股权登记日 2025 年 4 月 17 日（星期四）下午收市时，在中国证券 登记结算有限公司深圳分公司登记在册的公司全体股东均有权出席股东大会，并 可以以书面形式委托代理人出席会议和参加表决，该股东代理人不必是本公司股 东。 （2）公司董事、监事和高级管理人员。 （3）公司聘请的律师。 政法规、部门规章、规范性文件和《公司章程》的 ...

Core Points - The articles outline the draft articles of association for Zhejiang Sanhua Intelligent Controls Co., Ltd, which aims to protect the rights of the company, shareholders, and creditors while regulating organizational behavior [2][3][4] Chapter Summaries Chapter 1: General Provisions - The company is established as a joint-stock limited company in accordance with the Company Law and other relevant regulations [2] - The company was approved by the Zhejiang Provincial Government and registered with the Zhejiang Administration for Industry and Commerce [2][3] - The registered capital of the company is specified, and the chairman serves as the legal representative [4] Chapter 2: Business Objectives and Scope - The company's business objective is centered on economic efficiency, optimizing product structure, and developing core technologies to create value for shareholders and serve society [6] - The business scope includes research and development of household appliances, manufacturing of refrigeration and air conditioning equipment, and import/export of goods and technology [6] Chapter 3: Shares - The company's shares are issued in the form of stocks, with principles of openness, fairness, and justice governing the issuance [6][7] - The company has issued a total of 30 million shares, with specific allocations to various stakeholders during its establishment [7] Chapter 4: Shareholders and Shareholder Meetings - Shareholders have rights proportional to their shareholdings, including the right to dividends, voting rights, and the right to supervise the company's operations [14][15] - The company must hold annual shareholder meetings and provide adequate notice to shareholders regarding meeting details and proposals [42][54] Chapter 5: Shareholder Meeting Procedures - The procedures for convening shareholder meetings, including the rights of shareholders to propose agenda items and the requirements for voting, are clearly defined [60][77] - Special resolutions require a higher threshold of approval compared to ordinary resolutions, particularly for significant corporate actions [79][80]

Group 1 - The company, Shanghai Xuerong Biotechnology Co., Ltd., has announced the first extraordinary general meeting of shareholders for 2025, scheduled for April 11, 2025, at 14:30, combining both in-person and online video formats [1][2] - The network voting will take place on the same day, with specific time slots for voting through the Shenzhen Stock Exchange trading system and internet voting system [1][2] - Shareholders must hold shares as of the registration date, April 7, 2025, to attend the meeting and can authorize representatives to vote on their behalf [2][3] Group 2 - The meeting will review a proposal to provide guarantees for the subsidiary Chengdu Xuerong's application for comprehensive credit from Jindu Village Bank [2][3] - Voting will be non-cumulative, and shareholders can express their opinions as agree, disagree, or abstain [6][8] - The company has provided detailed instructions for participating in the network voting process, including identity verification requirements [6][10]

英科医疗: 关于召开公司2025年第二次临时股东大 会的通知 证券代码：300677 证券简称：英科医疗 公告编号：2025-030 英科医疗科技股份有限公司 关于召开公司 2025 年第二次临时股东大会的通知 本公司及董事会全体成员保证公告内容真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 英科医疗科技股份有限公司（以下简称"公司"）于 2025 年 3 月 （星期三）14:00 召开公司 2025 年第二次临时股东大会。 现将会议相关事项通知如下： 一、召开会议的基本情况 律、法规、部门规章、规范性文件及《英科医疗科技股份有限公司章 程》的规定。 （1）现场会议召开时间：2025 年 4 月 9 日（星期三）14:00 （2）网络投票时间：2025 年 4 月 9 日。其中，通过深圳证券交 易所交易系统进行网络投票的时间为 2025 年 4 月 9 日 9:15-9:25， 体时间为 2025 年 4 月 9 日 9:15-15:00。 司将通过深圳证券交易所交易系统和互联网投票系统 （http://wltp.cninfo.com.cn）向公司股东提供网络形式的投票平台，股 东可以在网络投票时间 ...

证券代码：600520 证券简称：文一科技 公告编号：2025-013 文一三佳科技股份有限公司 关于召开 2025 年第二次临时股东大会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 (一) 股东大会类型和届次 2025 年第二次临时股东大会 召开的日期时间：2025 年 3 月 19 日 14 点 30 分 召开地点：安徽省铜陵市铜官区石城路文一三佳科技股份有限公司 5 号楼党 群活动服务中心三楼会议室。 股东大会召开日期：2025年3月19日 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 (二) 股东大会召集人：董事会 (三) 投票方式：本次股东大会所采用的表决方式是现场投票和网络投票相结 合的方式 (四) 现场会议召开的日期、时间和地点 (五) 网络投票的系统、起止日期和投票时间。 无。 二、 会议审议事项 本次股东大会审议议案及投票股东类型 | 序号 | 议案名称 | 投票股东类型 | | --- | --- | --- | | | | 股股东 ...

证券代码：002271 证券简称：东方雨虹 公告编号：2025-031 北京东方雨虹防水技术股份有限公司 关于召开2024年年度股东大会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、召开会议的基本情况 7．出席对象： 2．股东大会的召集人：公司第八届董事会 3．会议召开的合法、合规性：本次股东大会会议的召开符合《公司法》、 《证券法》、《上市公司股东大会规则》、《深圳证券交易所股票上市规则》、 《深圳证券交易所上市公司自律监管指引第1号——主板上市公司规范运作》等 法律、法规、深圳证券交易所业务规则和《公司章程》等的规定。 4．会议召开的日期、时间： 现场会议时间为：2025年3月21日（星期五）下午14时30分 网络投票时间为：2025年3月21日（星期五） 其中，通过深圳证券交易所交易系统进行网络投票的具体时间为：2025年3 月21日的交易时间，即上午9:15—9:25，9:30—11:30和下午13:00—15:00；通 过深圳证券交易所互联网投票系统进行网络投票的具体时间为：2025年3月21日 上午9:15至下午15:00期间的任意时 ...

法律意见书 北京炜衡（成都）律师事务所 关于成都高新发展股份有限公司2025年第一次临时股东大会 的法律意见书 致：成都高新发展股份有限公司 北京炜衡（成都）律师事务所（以下简称"本所"），接受成 都高新发展股份有限公司（以下简称"公司"）委托，指派本所律 师出席公司于2025年2月25日召开的2025年第一次临时股东大会 （以下简称"本次大会"），对本次大会的相关事项进行见证并出 具法律意见。 为出具本法律意见书，本所律师出席了本次大会，审查了公司 提供的有关本次大会各项议程及相关文件，听取了公司董事会就有 关事项所作的说明。 在审查有关文件的过程中，公司向本所律师保证并承诺，其向 本所提交的文件和所作的说明是真实的，并已经提供本法律意见所 必需的、真实的原始书面材料、副本材料或口头证言，有关副本材 料或复印件与原件一致。 本所律师依据《中华人民共和国公司法》、《中华人民共和国 证券法》、《上市公司股东大会规则》、《律师事务所从事证券法 律业务管理办法》、其它相关法律、法规、规范性文件及公司章程 的规定，并按照律师行业公认的业务标准、道德规范及勤勉尽责精 神，出具法律意见如下： 一、 关于公司本次大会的召集 ...